Leading consultant pharmacists Neil Petrie and Ingrid Johnston have won the 2016 Pharmaceutical Society of Australia (PSA) Award for Quality Use of Medicines (QUM) in Pain Management. As the peak national body for pharmacists, PSA has partnered with Mundipharma to offer the 2016 QUM Award to...
Mundipharma Pty Limited (Mundipharma) is proud to announce that they have been selected as finalists of the Best Leadership Development Program and Best Change Management Strategy categories at the prestigious Australian HR Awards which they entered this year for the first time. These awards bring together...
Raising awareness around the correct first aid treatment for minor burns. National Burns Awareness Month will be held for the first time in June 2016, to provide awareness around the correct first aid treatment for minor burns. It is being led by the Julian Burton Burns Trust, Australia's...
Please be aware that Dilaudid-HP injection 500mg/50mL vial will be discontinued as of 31 August 2016. Dilaudid injection (ampoules 2mg/1mL); and Dilaudid-HP injection (ampoule 10mg/1mL and 50mg/5mL) remain available. Full information about our products, including the PIs and CMIs are available here. ® DILAUDID is a registered trade...
May 2016: For the second consecutive year, Mundipharma has won the Award for Medium Ethical Suppliers with a focus on achieving excellence in Engaging with Symbion in all aspects of the business. The Award was received on 18 May in Melbourne in front of 200 guests...
Acquires licensing rights to formulated hydration product for pregnant and breastfeeding women Sydney, Australia, 17 May 2016: Mundipharma Pty Limited (Mundipharma) today announced an exclusive licensing agreement for hydration product aquamamma® in Australia and New Zealand. In the last couple of years, Obstetrician Dr Rob Buist became...
Anti-emetic products covered under the sublicense agreement include ALOXI (palonosetron hydrochloride) and AKYNZEO (netupitant/palonosetron) Melbourne, Australia, 7 March 2016: Specialized Therapeutics Pty Ltd and Mundipharma Pty Limited today announce a sublicense agreement enabling Mundipharma to assume all commercialisation responsibilities for the anti-emetic products ALOXI® (palonosetron hydrochloride)...
Nominations are now open for an educational grant to be awarded to an Australian pharmacist who has made an outstanding contribution to the Quality Use of Medicines through clinical care of consumers with persistent pain. Australia’s peak organisation for pharmacists, the Pharmaceutical Society of Australia (PSA)...
Sydney, 4th February, 2016: MPL staff headed to the Sydney Cricket Ground to support the Pain Research Management Institute and raise awareness against chronic pain. The day started with a cricket Marathon where MPL employees were privileged to play a game of cricket on the Sydney...